Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Multicentre, Double-blind, Randomised Parallel-group Trial to Determine Whether Reducing Post-prandial Glycaemia Can Reduce Cardiovascular-related Morbidity and Mortality in Patients With Established Coronary Heart Disease or Acute Coronary Syndrome Who Have Impaired Glucose Tolerance

NCT00829660 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT00829660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00829660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Multicentre, Double-blind, Randomised Parallel-group Trial to Determine Whether Reducing Post-prandial Glycaemia Can Reduce Cardiovascular-related Morbidity and Mortality in Patients With Established Coronary Heart Disease or Acute Coronary Syndrome Who Have Impaired Glucose Tolerance
Lead sponsor
University of Oxford
Phase
Phase 4
Overall status
Completed
Start date
February 17, 2009
Completion date
April 18, 2017
Enrollment
6,526 (actual)
Sites
177

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, coronary heart disease, impaired glucose tolerance, type 2 diabetes mellitus (t2dm)